Who isn’t taking diabetes medication as prescribed? 10 March 2020 Managing blood glucose levels is a critical part of living well with type 2 diabetes but it can be difficult for many people. In fact, studies have shown that around half of all Australians have difficulty achieving their recommended HbA1c targets. One important factor in this is people not taking diabetes medication as prescribed. Now, thanks to a grant from the Diabetes Australia Research Program, the University of Sydney’s Dr Crystal Lee is trying to identify factors that are related to people not taking medication as regularly as they should. “Blood glucose lowering medications are an integral part of managing blood glucose levels, yet, according to a small-scale survey conducted in New South Wales, a third of the respondents were not taking their medications as regularly as they should,” Dr Lee said. “I’ll be using a number of different datasets joined together to identify any patterns of people who aren’t taking their medication as often as they are recommended. “This may help us work out whether this issue is more common in men or women, people of a certain age or socio-economic background. “Hopefully we will be able to get a better understanding of the impact of this as well. I’m really interested in understanding whether or not taking medication as often as prescribed leads to decreased hospitalisations and deaths.” Dr Lee thanked Diabetes Australia for funding diabetes research. “We need to understand how best to keep people healthy and out of hospital and the Diabetes Australia Research Program helps ensure Australia’s diabetes researchers can continue to do their important work.”
News 27 May 2026 Urgent product correction for MiniMed Android App Medtronic and the Therapeutic Goods Administration have issued an Urgent Product Correction for a MiniMed Mobile App Android software version... Continue Reading
News 27 May 2026 Tzield listing a game-changer for early-stage type 1 diabetes The first new therapy for type 1 diabetes in nearly a century, which works to delay the need for insulin therapy in type 1 diabetes, has been approved for use in Australia by the Therapeutic Goods Administration. Continue Reading
News 27 May 2026 Important recall: Selected Omnipod® 5 and Omnipod DASH® Pods Insulet has issued a critical recall affecting specific lots of Omnipod 5 and Omnipod DASH Pods after identifying a manufacturing... Continue Reading